At the two participating study sites, a total of seven doses of SDZ OST-S77 will be administered to each of l8 evaluable patients on study days 0,1,3,7, 14,21 and 35. These will be three dosage cohorts of six patients each.
Showing the most recent 10 out of 465 publications